These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9374374)

  • 21. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas.
    Shibata D; Schaeffer J; Li ZH; Capella G; Perucho M
    J Natl Cancer Inst; 1993 Jul; 85(13):1058-63. PubMed ID: 8515492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptide nucleic acid clamp PCR: a novel K-ras mutation detection assay for colorectal cancer micrometastases in lymph nodes.
    Taback B; Bilchik AJ; Saha S; Nakayama T; Wiese DA; Turner RR; Kuo CT; Hoon DS
    Int J Cancer; 2004 Sep; 111(3):409-14. PubMed ID: 15221969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of mutated K-ras DNA in urine, plasma, and serum of patients with colorectal carcinoma or adenomatous polyps.
    Su YH; Wang M; Brenner DE; Norton PA; Block TM
    Ann N Y Acad Sci; 2008 Aug; 1137():197-206. PubMed ID: 18837947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modified mismatch polymerase chain reaction-restriction fragment length polymorphism detected mutations in codon 12 and 13 of exon 2 of K-
    Faleel FD; Zoysa MI; Lokuhetti MD; Gunawardena YI; Chandrasekharan VN; Dassanayake RS
    J Cancer Res Ther; 2016; 12(4):1272-1277. PubMed ID: 28169239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent detection of K-ras mutation in stool samples of colorectal carcinoma patients after improved DNA extraction: comparison with tissue samples.
    Ito Y; Kobayashi S; Taniguchi T; Kainuma O; Hara T; Ochiai T
    Int J Oncol; 2002 Jun; 20(6):1263-8. PubMed ID: 12012008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative detection of mutant alleles of the K-ras gene with minor groove binder-conjugated fluorogenic DNA probes.
    Itabashi T; Maesawa C; Uchiyama M; Higuchi T; Masuda T
    Int J Oncol; 2004 Mar; 24(3):687-96. PubMed ID: 14767554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The balanced induction of K-ras codon 12 and 13 mutations in mucosa differs from their ratio in neoplastic tissues.
    Kraus MC; Seelig MH; Linnemann U; Berger MR
    Int J Oncol; 2006 Oct; 29(4):957-64. PubMed ID: 16964391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective study of K-ras mutations in the plasma of pancreatic cancer patients.
    Mulcahy HE; Lyautey J; Lederrey C; qi Chen X; Anker P; Alstead EM; Ballinger A; Farthing MJ; Stroun M
    Clin Cancer Res; 1998 Feb; 4(2):271-5. PubMed ID: 9516910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. K-ras codon 12 mutations may be detected in serum of patients suffering from adeno- and large cell lung carcinoma. A preliminary report.
    Kovalchuk O; Naumnik W; Serwicka A; Chyczewska E; Niklinski J; Chyczewski L
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():70-2. PubMed ID: 11820633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver.
    Schimanski CC; Linnemann U; Berger MR
    Cancer Res; 1999 Oct; 59(20):5169-75. PubMed ID: 10537293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. K-ras mutation detection in colorectal cancer using the Pyrosequencing technique.
    Poehlmann A; Kuester D; Meyer F; Lippert H; Roessner A; Schneider-Stock R
    Pathol Res Pract; 2007; 203(7):489-97. PubMed ID: 17629419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Greater frequency of K-ras Val-12 mutation in colorectal cancer as detected with sensitive methods.
    Carpenter KM; Durrant LG; Morgan K; Bennett D; Hardcastle JD; Kalsheker NA
    Clin Chem; 1996 Jun; 42(6 Pt 1):904-9. PubMed ID: 8665682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of APC and k-ras mutations in the serum of patients with colorectal cancer.
    Lauschke H; Caspari R; Friedl W; Schwarz B; Mathiak M; Propping P; Hirner A
    Cancer Detect Prev; 2001; 25(1):55-61. PubMed ID: 11270422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing.
    Schmiegel W; Scott RJ; Dooley S; Lewis W; Meldrum CJ; Pockney P; Draganic B; Smith S; Hewitt C; Philimore H; Lucas A; Shi E; Namdarian K; Chan T; Acosta D; Ping-Chang S; Tannapfel A; Reinacher-Schick A; Uhl W; Teschendorf C; Wolters H; Stern J; Viebahn R; Friess H; Janssen KP; Nitsche U; Slotta-Huspenina J; Pohl M; Vangala D; Baraniskin A; Dockhorn-Dworniczak B; Hegewisch-Becker S; Ronga P; Edelstein DL; Jones FS; Hahn S; Fox SB
    Mol Oncol; 2017 Feb; 11(2):208-219. PubMed ID: 28106345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased farnesyltransferase activity in human colorectal cancer: relationship with clinicopathological features and K-ras mutation.
    Caruso MG; Notarnicola M; Bifulco M; Laezza C; Guerra V; Altomare DF; Memeo V; Lorusso D; Demma I; Di Leo A
    Scand J Gastroenterol; 2003 Jan; 38(1):80-5. PubMed ID: 12608469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA.
    Marchese R; Muleti A; Pasqualetti P; Bucci B; Stigliano A; Brunetti E; De Angelis M; Mazzoni G; Tocchi A; Brozzetti S
    Pancreas; 2006 Mar; 32(2):171-7. PubMed ID: 16552337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of K-ras mutations in the plasma DNA of pancreatic cancer patients.
    Uemura T; Hibi K; Kaneko T; Takeda S; Inoue S; Okochi O; Nagasaka T; Nakao A
    J Gastroenterol; 2004 Jan; 39(1):56-60. PubMed ID: 14767735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disseminated colorectal tumor cells in organs prone to metastasis detected by new double enriched nested-PCR in comparison with recognized assays.
    Kraus MC; Linnemann U; Berger MR
    Oncol Rep; 2011 May; 25(5):1421-9. PubMed ID: 21369707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutant K-ras in apparently normal mucosa of colorectal cancer patients. Its potential as a biomarker of colorectal tumorigenesis.
    Minamoto T; Yamashita N; Ochiai A; Mai M; Sugimura T; Ronai Z; Esumi H
    Cancer; 1995 Mar; 75(6 Suppl):1520-6. PubMed ID: 7889485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
    Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
    Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.